Therapeutic Goods Committee (TGC)

The Therapeutic Goods Committee advises the Minister on standards for therapeutic goods, including labelling and packaging, and on principles to be observed in the manufacture of therapeutic goods for use in humans.

TGC members

To be advised

Secretary

Ms Lyn Lewis
Email: lyn.lewis@tga.gov.au
Telephone: 02 6232 8661
Fax: 02 6232 8442
Postal address: The Secretary, Therapeutic Goods Committee, PO Box 100, Woden ACT 2606

TGC stakeholder consultations

Current consultations

• Nil

Closed consultations

• Call for submissions: Development of a best practice guideline on non-reclosable packaging
  <http://www.tga.gov.au/packaging/nonrecpackinv.htm>
  closed 14 March 2008
• Revised general requirements for tablets and capsules
  <http://www.tga.gov.au/docs/html/tgo/drtgo78.htm>
  closed 7 March 2008
• Consultation on the adoption of Therapeutic Goods Order No. 77 - Microbiological standards for medicines under the Therapeutic Goods Act 1989
  <http://www.tga.gov.au/docs/html/tgo/drtgo77.htm>
  closed 7 March 2008
• Revised requirements for the labelling of medicines
  <http://www.tga.gov.au/label/drmeds.htm>
  closed 29 February 2008
• Revised requirements for child-resistant packaging
  <http://www.tga.gov.au/label/drcrp.htm>
  closed 22 February 2008
• Update to definition of 'British Pharmacopoeia' under the Therapeutic Goods Act 1989 - adoption of British Pharmacopoeia 2008 (BP 2008)
  <http://www.tga.gov.au/legis/bp2008cons.htm>
  closed 25 January 2008
• Revision of the Australian code of good wholesaling practice for therapeutic goods for human use
  <http://www.tga.gov.au/consult/2006/cgwp-dr.htm>
  closed 11 August 2006
• Adoption of British Pharmacopoeia 2005 (BP 2005)
  closed 24 February 2006

Top of page